Translation and validation of the Italian version of the postoperative quality of recovery score QoR-15

Picconi, Enzo; Iacobucci, Tiziana; Adducci, Enrica; Gualtieri, Elisabetta; Beccia, G.; Sollazzi, Liliana

doi:10.23736/s0375-9393.20.14472-9

Cited by 8 publications

(7 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All have found the translated instrument to be valid and reliable in measuring quality of recovery after surgery. A previous Italian translation and validation of the QoR-15 was proposed by Picconi et al in 2020(Picconi et al, 2020. Since it had not been published at the start of our clinical trial, we independently translated and validated the English version.…”

Section: Discussionmentioning

confidence: 99%

Factor structure of post-operative quality of recovery questionnaire (QoR-15): An Italian adaptation and validation

et al. 2023

View full text Add to dashboard Cite

BackgroundThe Quality of Recovery questionnaire (QoR-15) is an English instrument for measuring quality of recovery in surgical patients, not yet translated and validated in Italian when the Enhanced Recovery After Surgery (ERAS) Piemonte studies were planned.ObjectiveTo produce the Italian version of the QoR-15 questionnaire, to evaluate its factorial structure and to assess the invariance between two types of surgery.MethodsThe Italian version (QoR-15I) was obtained translating and adapting the original version to the Italian context. The validation was performed suppling the QoR-15I to 3,784 patients enrolled in two parallel stepped wedge cluster randomised trials (ERAS Colon-rectum Piemonte; ERAS Gyneco Piemonte). The factor structure and its invariance between types of surgery was tested using confirmatory bifactor model and multi-group analysis. Comparative fit index (CFI), root mean square error of approximation (RMSEA), and standardized root mean square residual (SRMR) fit indices and their changes between nested models were used to assess the factor structure and the invariance.ResultsThe bifactor model showed good fit (RMSEA = 0.049, CFI =0.957, SRMR = 0.036) and provided a general recovery factor and two specific factors for physical and mental recovery. Eighty-four percent of the common variance is attributable to the general factor, and thus the QoR-15I is sufficiently ‘one-dimensional’ with an adequate reliability (ωh = 0.70). The ωs values for the physical and mental recovery factors were 0.01 and 0.13, respectively. Multigroup analysis supported configural (RMSEA = 0.053, CFI = 0.950, SRMR = 0.035) and metric invariance (ΔRMSEA = -0.004; ΔCFI = -0.002; ΔSRMR = 0.014), whereas the intercept constraint was removed from item 15 to obtain partial scalar invariance (ΔRMSEA = 0.002; ΔCFI = 0.007; ΔSRMR = 0.004). Construct validity was supported by a negative association of QoR-15I scores with all variables related to worse patient condition and more complex surgery.ConclusionOur results support the use of the QoR-15I as a valid, reliable, and clinically feasible tool for measuring the quality of recovery after surgery. The results of the confirmatory factor analyses suggest that a unique recovery score can be calculated and support measurement invariance of the QOR-15I across the two type of surgery, suggesting that the questionnaire has the same meaning and the same measurement parameters in colorectal and gynaecologic patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Factor structure of post-operative quality of recovery questionnaire (QoR-15): An Italian adaptation and validation

et al. 2023

View full text Add to dashboard Cite

show abstract

“…It has been validated for patients undergoing ambulatory orthopaedic 14 ; general; cardiothoracic; gynecologic; orthopedic; cesarean delivery; urologic; plastic; vascular; and ear, nose, and throat or faciomaxillary surgery receiving general or regional anesthesia. 13 A systematic review of the measurement properties of QoR-15 concluded that it “fulfils requirements for outcome measurement instruments in clinical trials.” 15 Since the original publication of QoR-15 in 2013, it has been translated and validated in multiple languages, including Chinese, Danish, French, Italian, Korean, and Swedish, 16–21 further expanding its clinical use in an increasingly globalized world.…”

Section: Discussionmentioning

confidence: 99%

“…13 A systematic review of the measurement properties of QoR-15 concluded that it "fulfils requirements for outcome measurement instruments in clinical trials." 15 Since the original publication of QoR-15 in 2013, it has been translated and validated in multiple languages, including Chinese, Danish, French, Italian, Korean, and Swedish, [16][17][18][19][20][21] further expanding its clinical use in an increasingly globalized world.…”

Section: Discussionmentioning

confidence: 99%

“Patient-reported quality of recovery after local anesthesia versus brachial plexus block in hand surgery: a prospective randomized controlled study”

Meng

Baradaran

Jaberi

et al. 2023

Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

In hospitals worldwide, the benefits of local anesthesia (LA) have resulted in minor hand operations, such as carpal tunnel and trigger finger release, being moved out of the main operating room (OR). The sensory blockade, performed by the operating surgeon, uses LA with epinephrine to achieve pain control and Background: Both local anesthesia (LA) and brachial plexus (BP) anesthesia are commonly used in hand surgery. LA has increased efficiency and reduced costs, but BP is often favored for more complex hand surgery, despite requiring greater time and resources. The primary objective of this study was to assess the quality of recovery of patients who received LA or BP block for hand surgery. Secondary objectives were to compare postoperative pain and opioid use. Methods: This randomized, controlled, noninferiority study enrolled patients undergoing surgery distal to the carpal bones. Patients were randomized to either LA (wrist or digital block) or BP block (infraclavicular block) before surgery. Patients completed the Quality of Recovery-15 questionnaire on postoperative day (POD) 1. Pain level was assessed with a numeric pain rating scale, and narcotic consumption was recorded on POD1 and POD3. Results: A total of 76 patients completed the study (LA, n = 46, BP, n = 30). No statistically significant difference was found for median Quality of Recovery-15 score between LA [127.5 (interquartile range, 28)] and BP block [123.5 (interquartile range, 31)]. The inferiority margin of LA to BP block at the 95% confidence interval was less than the minimal clinically important difference of 8, demonstrating noninferiority of LA compared with BP block. There was no statistically significant difference between LA and BP block for numeric pain rating scale scores or narcotic consumption on POD1 and POD3 (P > 0.05). Conclusion: LA is noninferior to BP block for hand surgery with regard to patient-reported quality of recovery, postoperative pain, and narcotic use.

show abstract

“…The first specific instrument developed to measure and analyze pain caused by lesion of the nervous system was the Neuropathic Pain Scale (NPS), developed in 1997 [92,93].…”

Section: Pain Assessment Toolsmentioning

confidence: 99%

Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy

Pota,

Sansone,

De Sarno

et al. 2024

Behavioural Neurology

View full text Add to dashboard Cite

Amyotrophic lateral sclerosis (ALS) is the most frequent neurodegenerative disease of the motor system that affects upper and lower motor neurons, leading to progressive muscle weakness, spasticity, atrophy, and respiratory failure, with a life expectancy of 2–5 years after symptom onset. In addition to motor symptoms, patients with ALS have a multitude of nonmotor symptoms; in fact, it is currently considered a multisystem disease. The purpose of our narrative review is to evaluate the different types of pain, the correlation between pain and the disease’s stages, the pain assessment tools in ALS patients, and the available therapies focusing above all on the benefits of cannabis use. Pain is an underestimated and undertreated symptom that, in the last few years, has received more attention from research because it has a strong impact on the quality of life of these patients. The prevalence of pain is between 15% and 85% of ALS patients, and the studies on the type and intensity of pain are controversial. The absence of pain assessment tools validated in the ALS population and the dissimilar study designs influence the knowledge of ALS pain and consequently the pharmacological therapy. Several studies suggest that ALS is associated with changes in the endocannabinoid system, and the use of cannabis could slow the disease progression due to its neuroprotective action and act on pain, spasticity, cramps, sialorrhea, and depression. Our research has shown high patients’ satisfaction with the use of cannabis for the treatment of spasticity and related pain. However, especially due to the ethical problems and the lack of interest of pharmaceutical companies, further studies are needed to ensure the most appropriate care for ALS patients.

show abstract

Translation and validation of the Italian version of the postoperative quality of recovery score QoR-15

Cited by 8 publications

References 4 publications

Factor structure of post-operative quality of recovery questionnaire (QoR-15): An Italian adaptation and validation

Factor structure of post-operative quality of recovery questionnaire (QoR-15): An Italian adaptation and validation

“Patient-reported quality of recovery after local anesthesia versus brachial plexus block in hand surgery: a prospective randomized controlled study”

Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy

Contact Info

Product

Resources

About